[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oculis Holding Ag (OCS)

Oculis Holding Ag (OCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oculis Holding Ag BAHNHOFSTRASSE 20 ZUG V8 6300 CHE

www.oculis.com Employees: 60 P: 41-41-711-3960

Sector:

Medical

Description:

Oculis Holding AG is a biopharmaceutical company which develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidate includes OCS-01, OCS-02 and OCS-05. Oculis Holding AG is based in Zug, Switzerland.

Key Statistics

Overview:

Market Capitalization, $K 1,715,167
Enterprise Value, $K 1,617,007
Shares Outstanding, K 57,984
Float, K 57,984
% Float 100.00%
Short Interest, K 429
Short Float 0.74%
Days to Cover 2.59
Short Volume Ratio 0.40
% of Institutional Shareholders 22.30%

Financials:

Annual Sales, $ 1,450 K
Annual Net Income, $ -119,440 K
Last Quarter Sales, $ 510 K
Last Quarter Net Income, $ -30,680 K
EBIT, $ -98,570 K
EBITDA, $ -97,910 K

Growth:

1-Year Return 68.78%
3-Year Return 187.87%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.51 on 03/03/26
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -2.27
EPS Growth vs. Prev Qtr -27.50%
EPS Growth vs. Prev Year 32.89%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

OCS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.12%
Return-on-Assets % -49.75%
Profit Margin % -8,237.24%
Debt/Equity 0.00
Price/Sales 1,111.99
Price/Cash Flow N/A
Price/Book 6.80
Book Value/Share 4.08
Interest Coverage -117.49
60-Month Beta 0.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.